Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wyeth Pharmaceuticals

Division of Pfizer Inc.
www.wyeth.com

Latest From Vascular Solutions Inc.

Device Debuts: Spinal Innovation From NuVasive, Life Spine; Teleflex Targets EuroPCR For Arrow AC3 Optimus; Abiomed Pushes 3-G Impella

This edition of Device Debuts covers the innovative devices introduced into commercial markets since the mid-April, typically a busy time for product launches as it coincides with spring's big medical meetings. This includes a series of spine-surgery technologies showcased at the AANS meeting and devices that support blood circulation during interventions that were featured at EuroPCR and SCAI.

Orthopedics Cardiology

Teleflex Buys Vascular Solutions For $1bn To Improve Growth

The purchase price of $56 a share in cash is a modest 16% premium over Vascular Solutions' 90-day average price. Vascular Solutions' CEO says uncertainty about the future leadership of the company compelled it to consider acquisition offers.

Commercial Companies

Pharma Pricing, Non-Profit Ties Get Increasing Scrutiny From Prosecutors

Off-label marketing and kickbacks may no longer be the top targets of government healthcare fraud investigations as more companies are being hit with subpoenas for pricing information.

Legal Issues Policy

Acclarent Execs Move To Appeal Off-Label Conviction

Attorneys for former Acclarent executives William Facteau and Patrick Fabian have filed a request that their convictions on off-label marketing charges either be set aside or that they be granted a new trial, citing other recent off-label trials and misconduct by the government.

Medical Device Legal Issues
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Wyeth-Ayerst Laboratories
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • Joseph M Mahady, Pres.
    Mark Lee, PhD, SVP, Bus. Dev., Pharma & Head, Worldwide Licensing
    Gary L Stiles, MD, EVP, CMO
    Geno Germano, Pres., US & Gen. Manager
  • Contact Info
  • Wyeth Pharmaceuticals
    Phone: (610) 902-1200
    500 Arcola Rd.
    Collegeville, PA 19426
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register